Biotricity is trading at $0.11, up 13.68%, with the move appearing primarily linked to healthcare-sector strength.
- No new company-specific announcement or catalyst was identified for September 15, 2026.
- XLV was up 1.28% as investors favored defensive healthcare assets amid market volatility.
- Trading activity was light at approximately 1.3K shares, versus average daily volume of 87.34K.